In February 2024 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Hezron Karanja after his sample tested positive for the prohibited substance Triamcinolone acetonide.

Following notification a provisional suspension was ordered, yet ADAK was unable to locate the Athlete. Ultimately the Athlete failed to respond to the communications from ADAK, nor did he attend the hearing of the Sports Disputes Tribunal.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. 

The Panel determines that the Athlete was non responsive and didn't provide any statement in his defence. As a result the Panel deems that he failed to demonstrate that the violation was not intentional, nor how the substance had entered his system.

Therefore the Tribunal decides on 25 July 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 25 February 2024.

In July 2024 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Victor Kiptoo Kimutai after his sample tested positive for the prohibited substance Methasterone.

Following notification the Athlete timely admitted the violation, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by ADAK. 

Therefore the ADAK decides on 4 July 2024 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 3 July 2024.

The Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Paskalia Chepkorir after his sample tested positive for the prohibited substance Deflazacort.

Following notification the Athlete admitted the violation, waived his right for a hearing and accepted the sanction proposed by ADAK. 

Therefore ADAK decides on 16 February 2024 to impose a 2 year period of ineligibility on the Athlete, starting on 5 February 2024.

In February 2024 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Allan Kipkoech after his sample tested positive for the prohibited substance Testosterone and its metabolites.

Following notification a provisional suspension was ordered. The Athlete failed to respond to the communications from ADAK, nor attended the hearing of the Kenya Sports Disputes Tribunal.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. 

The Panel determines that the Athlete was non responsive and didn't provide any statement in his defence. As a result the Panel deems that he failed to demonstrate that the violation was not intentional, nor how the substance had entered his system.

Therefore the Tribunal decides on 4 July 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the decision.

In February 2024 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Alfred Biwott Chemeitoi after his sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone).

Following notification a provisional suspension was ordered. Thereupon the Athlete failed to respond, nor attended the Kenya Sports disputes Tribunal.

In view of the evidence the Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.

The Panel determines that the Athlete was non responsive and didn't provide any statement in his defence. As a result the Panel deems that he failed to demonstrate that the violation was not intentional, nor how the substance had entered his system.

Therefore the Tribunal decides on 25 July 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 25 February 2024.

In February 2024 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Joshua Kiplangat Belet after his sample tested positive for Testosterone and its metabolites.

Following notification ADAK was unable to locate the Athlete and he failed to respond. Thereupon the case was referred to the Kenya Sports Disputes Tribunal.

In view of the evidence the Panel finds that the presence of the prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. 

Without the Athlete's response the Panel deems that he failed to demonstrate that the violation was not intentional, nor how the substance had entered his system. Furthermore the Panel finds that there are no grounds for a reduced sanction.

Therefore the Panel decides on 30 July 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 13 February 2024.

In November 2023 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Joan Jeruto for her multiple evasion, refusal or failure to submit to sample collection in August 2023.

Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and the case was referred to the Kenya Sports Disputes Tribunal.

The Doping Control Officers in this case testified that the Athlete ran away from the training camp after she had been notified about the sample collection. The same day the DCOs and two coaches went the the Athlete's house.

At the house the Athlete failed to respond although there were signs that she was present. Ultimately late in the afternoon she opened the door.

Thereupon the Athlete was duly notified and identified by the DCOs.  When asked she gave evasive answers about her conduct that day.

At first it seemed that the Athlete was willing to submit to sample collection. Yet, after having a long phone call outside her house in sight of a DCO the Athlete locked the door and ran away from the house and disappeared. 

ADAK contended that there was sufficient evidence that the Athlete deliberately had avoided doping control without any compelling justification for her conduct after notification by the DCOs.

In her defence the Athlete acknowledged the notification and contradicted the testimonies of the DCOs. As a police officer she claimed that she had received threatening messages and the reason why she did not open the door and disappeared because the DCOs failed to identify themselves.

The Panel assessed and addressed the evidence regarding the Athlete's doping violation and determines that:

• The Athlete was properly identified and notified on both occasion by the DCOs in the presence of her coaches.
• The Athlete intentionally refused and evaded sample collection and accordingly committed an anti-doping rule violation.
• There are no grounds for a reduced sanction.

Therefore the Panel decides on 25 July 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 22 November 2023.

In March 2023 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Isgah Cheruto after her sample tested positive for the prohibited substances 19-norandrosterone an 19-noretiocholanolone (Nandrolone).

Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and the case was referred to the Kenya Sports Disputes Tribunal.

The Athlete accepted the test result and denied the intentional use of the substance. She stated that in 2022 she suffered from several medical conditions and had online purchased and used the medication Norethisterone as treatment. 

ADAK contended that the Athlete failed to demonstrate with evidence that the violation was not intentional, nor how the substance had entered her system. It deemed that the Athlete's use of the medication Norethisterone could not explain the presence of Nandrolone in her sample.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.

The Panel agrees that the Athlete failed to demonstrate with corroboration evidence that her violation was not intentional, nor how the prohibited substance had entered her system.

Therefore the Tribunal decides on 30 May 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 18 April 2024.

In July 2024 the Canadian Centre for Ethics in Sport (CCES) reported an anti-doping rule violation against the powerlifter Thande Hutt after his sample tested positive for the prohibited substances Amfetamine, Dehydrochlormethyltestosterone, GW1516 and GW501516. 

Furthermore CCES reported a second violation against the Athlete for his refusal to submit to sample collection on 14 June 2023.

Following Notification the Athlete gave a prompt admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by the CCES.

The CCES deems that there are aggravating circumstances present in this case and finds that both violations shall be considered as one single first anti-doping rule violation. Because the Athlete signed and submitted the Early Admission and Acceptance Form he received a 1 year reduction from CCES.

Therefore the CCES decides on 9 September 2024 to impose a 5 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 16 July 2024.

In April 2023 the ice skater Kamryn Lute (19) underwent medical treatment for her diagnosed condition. One of the prescribed supplements she used was HG Healthgevity.

The Athlete was added to the Registered Testing Pool since October 2021 and she was subjected to multiple sample collections between April 2023 and February 2024. On the Doping Control Form she mentioned the use of her supplement as HG Healthgevity BPC+PEA 500, 1 Capsule, once daily.

In March 2024 the United States Anti-Doping Agency (USADA) requested additional information regarding the Athlete's use of the HG Healthgevity supplement. The Athlete submitted to USADA her medical records and two bottles of the supplement.

In April 2024 the Salt Lake City Laboratory analysed the supplement and established that it contained the prohibited substances BPC-157 and Dehydroepiandrosterone (DHEA). BPC-157 was listed on the product label whereas DHEA was not listed as ingredient.

Consequently in April 2024 USADA reported an anti-doping rule violation against the Athlete for her use of the two prohibited substances. 

Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the New Era Arbitration Tribunal.

The Athlete had admitted the violation for her use of BPC-157 and DHEA. She denied that the violation was intentional and argued that she acted with No Significant Fault or Negligence.

USADA deemed that:

• The Athlete's violation was not intentional.
• The HG Healthgevity capsules were contaminated with DHEA.
• The Athlete mentioned the use of her supplement on the Doping Control Form.
• She suffered from several health issues.
• She acted negligently with her supplements.

The Arbitrator assessed and addressed the evidence and the Parties arguments and determines that:

• The Athlete committed an anti-doping rule violation because of her use of the HG Healthgevity supplement containing BPC- 157 and DHEA.
• The violation was not intentional and the DHEA would not effect the length of the sanction.
• Although tested repeatedly the Athlete never tested positive for BPC-157 and DHEA.
• The Athlete never received a Declaration Courtesy Letter from USADA regarding her use of BPC+PEA 500 mentioned on the Doping Control Form.
• The Athlete acted with Significant Fault or Negligence regarding the prescribed supplements.
• There are particular circumstances present in this case for the imposition of a reduced sanction.
• Fairness requires that the Athlete's results shall not be disqualified.

Therefore the Arbitration Tribunal decides on 20 August 2024 to impose a 1 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 10 April 2024.